Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center. - Test2 - elhamkhani - TriplyDB

Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center.

Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center.

http://www.wikidata.org/entity/Q33795389

about

"Stormy waters ahead": global emergence of carbapenemases Emergence of Carbapenemaseproducing Klebsiella Pneumoniae of Sequence type 258 in Michigan, USA The potential economic burden of Zika in the continental United States Comprehensive Genome Analysis of Carbapenemase-Producing Enterobacter spp.: New Insights into Phylogeny, Population Structure, and Resistance Mechanisms.The Complex Epidemiology of Carbapenem-Resistant Enterobacter Infections: A Multicenter Descriptive Analysis.Risk Factors and Outcomes for Carbapenem-Resistant Klebsiella pneumoniae Isolation, Stratified by Its Multilocus Sequence Typing: ST258 Versus Non-ST258.Retrospective analysis of fosfomycin combinational therapy for sepsis caused by carbapenem-resistant Klebsiella pneumoniae."Swimming in resistance": Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa.Carbapenem-resistant enterobacteriaceae: an emerging problem in children.Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogens.Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship.Pediatric carbapenem-resistant Enterobacteriaceae in Los Angeles, California, a high-prevalence region in the United States.Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia.The combination of doripenem and colistin is bactericidal and synergistic against colistin-resistant, carbapenemase-producing Klebsiella pneumoniae A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome.Prevalence of and risk factors for multidrug-resistant Acinetobacter baumannii colonization among high-risk nursing home residents.Early insights into the interactions of different β-lactam antibiotics and β-lactamase inhibitors against soluble forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3.Investigating the position of the hairpin loop in New Delhi metallo-β-lactamase, NDM-1, during catalysis and inhibitor binding Risk of infection following colonization with carbapenem-resistant Enterobactericeae: A systematic review.Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method.The role of antimicrobial stewardship in curbing carbapenem resistance.Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How?Predictors of Persistent Carbapenem-Resistant Enterobacteriaceae Carriage upon Readmission and Score Development.Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities.Carbapenem-resistant Enterobacteriaceae in pediatric patients: epidemiology and risk factors.Evidence from a New York City hospital of rising incidence of genetically diverse carbapenem-resistant Enterobacter cloacae and dominance of ST171, 2007-14.Carbapenem-resistant Enterobacter cloacae isolates producing KPC-3, North Dakota, USA.Co-colonization with carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii in intensive care unit patients.Antimicrobial resistance: one world, one fight!.Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan.MALDI-TOF MS Identification and Clustering Applied to Species in Nosocomial Setting

P2860

Q21131125-92AE23F9-987A-401B-B7D2-9C61827104CC Q27009117-B13EB167-EDAA-4A0F-9BD8-2A8BECFBB85C Q29587258-F6B9CA0F-C4BA-44A9-B12E-2F70270552E4 Q30354711-5B4FA70E-7430-4D51-875B-3EDEAFC52894 Q30379480-C1A6EE38-F51A-436C-8FC7-19C587AF3A3D Q30384546-EC1E3F9C-32AC-4B33-8BF6-B53F897404A7 Q33597689-9014BEE1-2DEE-4A3A-96AF-800B3E3EDCA1 Q33648238-B442A0AE-FA01-49AC-AEE7-981E3F2CA77C Q34281727-AE45A2E6-6742-49B6-B178-723A8E95A04C Q34320945-4B897FFE-E96C-4BEC-B754-392E1FDD6384 Q34336456-6166F703-0A02-475C-A17C-E20FC12A4EDB Q34366895-E0DAD896-760F-47B6-A028-C7A72BC0CE3F Q35207767-244CDDAC-4E23-4F33-840E-6D1ADD031B96 Q35624517-969CD84F-54C4-4AB0-A05E-A21D2754AE0D Q35867414-62921217-345A-4EDC-B84D-EA9C2E88E738 Q35941296-AEEF7E09-BC73-4677-B833-5BA486614E98 Q36018869-F092A890-4EFA-4FF9-8723-5F6D6EA3D73F Q36181417-6A631355-29AA-4FDC-A090-A7BDAC0B32CF Q36225143-2F527BCE-E890-4727-97C7-62D093CFC0B0 Q36364023-EFCCC44D-5D4F-4442-A463-EAE334C42104 Q36832336-58C553D5-DD95-4E8E-B2EF-0B627381DC49 Q37603930-2F75B895-B50E-4300-8AFA-0FF04661BF11 Q37713697-328C95A7-8A13-4983-B457-EC85778ED94B Q38125493-1F5B9F9E-AA56-4E9B-AC6E-8BE0DE71A4E6 Q38998702-438005DD-E3E3-41FF-93F7-335F009455B4 Q40124147-167FBC9B-3AB8-46C6-AD29-5103E60A4479 Q40175800-337DFCC0-44B4-4BAE-818E-7052B0502125 Q42225305-2DA87E3D-4D15-4ACE-B111-E5D638E84FE1 Q42410052-1979D47E-0870-4B85-9682-CBEDDDAECA9E Q42920008-24664EDA-565B-400D-93F8-28DE38B7D332 Q44884892-144FF2F5-ED7F-48C9-A9B8-27770B74D0A6 Q45920711-77045D8F-2331-415D-A6F6-99DE49189BF0 Q51104523-DF66731B-8FEA-4E7D-9032-3C1717B44A27 Q58781704-CF31A7D0-E298-4020-A87E-CC81FC554C90

P2860

Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center.

http://www.wikidata.org/entity/Q33795389

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Outcomes and genetic relatedne ...... eae at Detroit medical center.

@ast

Outcomes and genetic relatedne ...... eae at Detroit medical center.

@en

type

label

Outcomes and genetic relatedne ...... eae at Detroit medical center.

@ast

Outcomes and genetic relatedne ...... eae at Detroit medical center.

@en

prefLabel

Outcomes and genetic relatedne ...... eae at Detroit medical center.

@ast

Outcomes and genetic relatedne ...... eae at Detroit medical center.

@en

P1433

Q33795389-93F7F898-7894-490F-A74A-4E2E7B3F01BB

P1476

Q33795389-3AFDC08E-F8F6-44AD-A2C8-E65692214AEF

P2093

Q33795389-00971AC0-1A1A-481A-B805-DDA0F7EE1782

Q33795389-2FFD6046-1CDC-41DB-AC65-0839BA14958C

Q33795389-3AB6D5A7-3BAB-4250-8445-632B8CAC2B53

Q33795389-4629F575-B8D8-49CC-A9D8-2CBD9EA28BE6

Q33795389-4F6EADA3-84E1-4296-8F2F-CE16C1989F3C

Q33795389-5831FA56-E8CE-473A-A633-E67EDCE02187

Q33795389-5D51DF8D-1807-4CA9-8016-9A9A572D1117

Q33795389-654BFB69-D9D8-4DFC-8ECA-1971B98263D7

Q33795389-657E233A-41D5-4590-A43C-8E65028BA4DC

Q33795389-6A13245F-21BD-4286-ABEC-493A4D790275

P2860

Q33795389-045D6DD0-F592-4132-AB8F-A1D40BB577EB

Q33795389-1059DD9E-6A9A-4FB8-9605-25AED1F1C265

Q33795389-14082042-83EC-4383-B812-D3EF576F58C5

Q33795389-22F3BC36-DF83-4FA1-B13E-6036365643A5

Q33795389-27CC1FCB-4C89-408B-A6EB-DBBF630D2421

Q33795389-46055F96-7D44-42D9-A5A0-98A50BF924D3

Q33795389-4CAE4076-62CD-43DA-AA6A-A368B29E54B2

Q33795389-5A78DBE4-E2E4-4B8B-834C-2234D87ADF89

Q33795389-5DE99ADE-8C3C-410E-A8F2-818A1CCD4C38

Q33795389-626DA56E-1062-4349-9A13-3E18477CD114

P304

Q33795389-B3E8831E-9536-4E18-90AE-5F6DEF82E8BF

P31

Q33795389-3AAB2CAB-7305-494A-9441-978E95020B01

P356

Q33795389-FE4FCFDA-7414-4746-8446-2D465F22C273

P433

Q33795389-D74F4EBB-F0DF-42A5-A1E6-54F9365048EB

P478

Q33795389-59776DEF-032A-4EDA-9064-C1A01DEC7B21

P50

Q33795389-20955026-5E3F-42AB-BFBE-0DEE4C0A3E4E

Q33795389-5147B6DF-A6C0-4024-8422-5DC11FBD963A

Q33795389-C9AE0BE4-8B44-4B91-9DCE-E5A827891A9B

Q33795389-E375FD9F-76B0-4393-BD23-7337D042362D

P577

Q33795389-23C3DCD4-51E6-42BE-8687-F44347C7A8D9

P5875

Q33795389-0088E8B2-B295-4E5D-B79F-0903FD8DCD60

P698

Q33795389-F68C610E-CBE9-43C3-B92C-B35E580058C7

P921

Q33795389-8B09E3BB-0C9D-4701-BE44-052AF0638EAD

P932

Q33795389-CB560D77-CE30-447F-BBB9-0EA29132A0BB

P356

P1433

Infection Control and Hospital Epidemiology

P1476

Outcomes and genetic relatedne ...... eae at Detroit medical center.

@en

P2093

Christopher Blunden

http://www.w3.org/2001/XMLSchema#string

Diixa Patel

http://www.w3.org/2001/XMLSchema#string

Dror Marchaim

http://www.w3.org/2001/XMLSchema#string

Farah Ahmad

http://www.w3.org/2001/XMLSchema#string

Federico Perez

http://www.w3.org/2001/XMLSchema#string

Hossein Salimnia

http://www.w3.org/2001/XMLSchema#string

Jason M Pogue

http://www.w3.org/2001/XMLSchema#string

Jastin Varkey

http://www.w3.org/2001/XMLSchema#string

Jessica Slim

http://www.w3.org/2001/XMLSchema#string

Keith S Kaye

http://www.w3.org/2001/XMLSchema#string

P2860

Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae

Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections.

Risk factors and outcomes associated with acquisition of colistin-resistant KPC-producing Klebsiella pneumoniae: a matched case-control study.

Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.

Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination.

Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection.

Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae.

P304

861-871

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/661597

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Kayoko Hayakawa

Robert A Bonomo

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51559285

http://www.w3.org/2001/XMLSchema#string

P698

21828966

http://www.w3.org/2001/XMLSchema#string

P921

carbapenem antibiotic

P932

4067763

http://www.w3.org/2001/XMLSchema#string